HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
EXAS [NASD]
Exact Sciences Corporation
Healthcare | Diagnostics & Research | USA
statements
Index- P/E- EPS (ttm)-4.32 Insider Own0.90% Shs Outstand174.42M Perf Week-8.90%
Market Cap6.77B Forward P/E- EPS next Y-3.13 Insider Trans-6.69% Shs Float174.35M Perf Month-15.16%
Income-745.40M PEG- EPS next Q-1.07 Inst Own94.60% Short Float6.62% Perf Quarter-41.18%
Sales1.85B P/S3.66 EPS this Y36.20% Inst Trans4.92% Short Ratio5.18 Perf Half Y-47.19%
Book/sh18.68 P/B2.20 EPS next Y23.70% ROA-11.20% Target Price96.53 Perf Year-66.84%
Cash/sh4.96 P/C8.29 EPS next 5Y- ROE-21.80% 52W Range35.34 - 125.60 Perf YTD-47.15%
Dividend- P/FCF- EPS past 5Y-16.30% ROI-10.90% 52W High-67.25% Beta1.27
Dividend %- Quick Ratio2.30 Sales past 5Y77.80% Gross Margin73.90% 52W Low16.38% ATR3.02
Employees6420 Current Ratio2.50 Sales Q/Q21.00% Oper. Margin-39.50% RSI (14)44.41 Volatility6.06% 6.64%
OptionableYes Debt/Eq0.68 EPS Q/Q-464.00% Profit Margin-40.30% Rel Volume0.65 Prev Close39.39
ShortableYes LT Debt/Eq0.67 EarningsApr 26 AMC Payout- Avg Volume2.23M Price41.13
Recom1.60 SMA20-2.62% SMA50-16.98% SMA200-44.02% Volume1,451,559 Change4.42%
Jun-03-22Initiated Piper Sandler Neutral $50
Nov-03-21Downgrade Raymond James Strong Buy → Outperform $160 → $130
Jul-29-21Reiterated Stifel Buy $165 → $145
Jul-29-21Reiterated Oppenheimer Outperform $161 → $155
Jul-29-21Reiterated Canaccord Genuity Buy $185 → $160
Jul-29-21Reiterated BTIG Research Buy $155 → $145
Jun-15-21Initiated Raymond James Strong Buy $160
Jun-03-21Initiated Goldman Buy $160
May-25-21Initiated Wells Fargo Equal Weight $115
Jan-28-21Initiated Truist Buy $226
Oct-29-20Downgrade UBS Buy → Neutral $125 → $140
Oct-28-20Downgrade Citigroup Buy → Neutral $120 → $140
Oct-08-20Resumed BTIG Research Buy $140
Apr-02-20Initiated Evercore ISI Outperform $70
Jan-10-20Resumed BTIG Research Buy $127
Jan-07-20Initiated Citigroup Buy $120
Dec-13-19Initiated Dougherty & Company Buy $120
Nov-15-19Initiated Stifel Buy
Oct-17-19Reiterated BofA/Merrill Buy $130 → $135
Oct-01-19Resumed Craig Hallum Buy $127
Jun-30-22 10:20AM  
Exact Sciences (EXAS) Cologuard Growth Robust Amid Margin Woes
Zacks
Jun-28-22 11:58AM  
ARKK ETF sees inflow streak as Cathie Wood acknowledges inflation
Yahoo Finance Video -6.78%
Jun-27-22 09:13AM  
Exact Sciences (EXAS) Surges 6.9%: Is This an Indication of Further Gains?
Zacks
Jun-21-22 06:00AM  
Ultima Genomics and Exact Sciences enter long-term supply agreement aimed at improving patient access to genomic testing by driving down sequencing costs
PR Newswire
Jun-14-22 10:47AM  
Cathie Woods ARK Innovation ETF nears pandemic low amid market meltdown
Yahoo Finance Video
Jun-09-22 11:00AM  
5 Cathie Wood Stocks to Buy in June
InvestorPlace -9.90%
May-30-22 10:53AM  
12 Best ARK Stocks To Buy Now
Insider Monkey
May-27-22 08:50AM  
Exact Sciences Showcases Breadth of Early Detection and Treatment Guidance Portfolio with Multiple Data Presentations at ASCO 2022
PR Newswire +7.96%
06:00AM  
Exact Sciences to participate in June investor conferences
PR Newswire
May-26-22 02:17PM  
Why Is Exact Sciences (EXAS) Down 22.5% Since Last Earnings Report?
Zacks
May-23-22 11:22AM  
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock
Zacks
May-06-22 10:58AM  
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Barrons.com
May-03-22 10:39AM  
Guardant Launches a Blood Screen for Cancer, in Challenge to Illumina and Exact Sciences
Barrons.com
May-02-22 06:00AM  
Exact Sciences to participate in May investor conference
PR Newswire
Apr-28-22 09:00AM  
Updated ASCO Guidelines Strongly Recommend Use of the Oncotype DX Breast Recurrence Score® Test in Node-Negative and the Majority of Node-Positive Early-Stage Breast Cancer Patients
PR Newswire -7.98%
Apr-27-22 10:25AM  
Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up
Zacks +6.63%
09:54AM  
Non-COVID Sales Boost Exact Sciences' Q1 Revenue; Revises FY22 Guidance
Benzinga
09:41AM  
How Exact Sciences Aims to Keep Its Lead in Cancer Tests
Barrons.com
12:30AM  
Exact Sciences (EXAS) Q1 2022 Earnings Call Transcript
Motley Fool
Apr-26-22 06:05PM  
Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates
Zacks -6.40%
Apr-22-22 02:15AM  
I Tried a New Test That Screens for 50 Kinds of Cancer. What I Learned.
Barrons.com
Apr-08-22 06:00AM  
Exact Sciences schedules first quarter 2022 earnings call
PR Newswire
Apr-07-22 10:30AM  
2 Top Biotech Stocks to Buy for the Long Haul
Motley Fool
Mar-31-22 08:54AM  
Here's Why You Should Hold on to Exact Sciences (EXAS) Stock
Zacks
Mar-30-22 06:15PM  
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Zacks
Mar-24-22 11:30AM  
Exact Sciences (EXAS) Down 4.3% Since Last Earnings Report: Can It Rebound?
Zacks
Mar-15-22 06:15PM  
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
Zacks
11:34AM  
Exact Sciences (EXAS) Cologuard Sales Up but Costs Rise
Zacks
Mar-09-22 06:15PM  
Exact Sciences (EXAS) Gains But Lags Market: What You Should Know
Zacks
Mar-07-22 09:00AM  
Katie Couric and Cologuard Team Up to Spread Awareness and Urgency for People to Get Screened for Colon Cancer
PR Newswire
Mar-01-22 08:30AM  
Diversey Appoints Katherine S. Zanotti to its Board of Directors
GlobeNewswire
Feb-28-22 06:00AM  
Exact Sciences to participate in March investor conferences
PR Newswire
Feb-24-22 02:15PM  
10 Stocks in Focus After Posting Their Earnings Reports
Insider Monkey +9.52%
10:45AM  
Invest in Next-Gen Technologies With These 2 ETFs
Motley Fool
Feb-23-22 09:38AM  
Cancer-Test Maker Exact Sciences Saw Strong Revenue Growth
Barrons.com -6.07%
07:53AM  
Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down
Zacks
Feb-22-22 06:05PM  
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Exact Sciences Announces Fourth Quarter 2021 Results
PR Newswire
Feb-21-22 09:30AM  
3 Stocks to Avoid This Week
Motley Fool
Feb-18-22 06:15PM  
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Zacks
Feb-16-22 09:37AM  
Heres Why You Should Remain Optimistic in Exact Sciences Corp. (EXAS)
Insider Monkey
Feb-10-22 11:55AM  
Cathie Woods Ark Invest files to to launch venture fund
Yahoo Finance Video
Feb-09-22 09:59AM  
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
Zacks
Feb-08-22 06:15PM  
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Zacks
03:00PM  
Earnings Preview: Exact Sciences (EXAS) Q4 Earnings Expected to Decline
Zacks
06:00AM  
Exact Sciences schedules fourth quarter 2021 earnings call
PR Newswire
Feb-03-22 11:20AM  
Were Expert Investors Right About EXACT Sciences Corporation (EXAS)?
Insider Monkey
09:38AM  
Redwood Investments, LLC Buys Asbury Automotive Group Inc, Avid Bioservices Inc, SiTime Corp, ...
GuruFocus.com
Feb-02-22 01:38PM  
C WorldWide Group Holding A Buys Adobe Inc, Align Technology Inc, NovoCure, Sells Visa Inc, ...
GuruFocus.com
03:52AM  
Is Exact Sciences Ready to Attempt Another Rally?
TheStreet.com
Feb-01-22 06:15PM  
Exact Sciences (EXAS) Outpaces Stock Market Gains: What You Should Know
Zacks
06:00AM  
Exact Sciences to participate in February investor conferences
PR Newswire
Jan-31-22 01:38PM  
SignalPoint Asset Management, LLC Buys Exact Sciences Corp, iShares Russell 1000 Value ETF, ...
GuruFocus.com +8.81%
Jan-26-22 06:15PM  
Exact Sciences (EXAS) Dips More Than Broader Markets: What You Should Know
Zacks
05:38PM  
Patten & Patten Inc Buys JPMorgan Equity Premium Income ETF, Delta Air Lines Inc, Lincoln ...
GuruFocus.com
05:38PM  
Resonant Capital Advisors, LLC Buys Marqeta Inc, Vanguard Tax-Exempt Bond ETF, iShares National ...
GuruFocus.com
05:38PM  
Berger Financial Group, Inc Buys Hartford Core Bond ETF, Apple Inc, Independence Realty Trust ...
GuruFocus.com
05:38PM  
LaFleur & Godfrey LLC Buys Medtronic PLC, Goldman Sachs Group Inc, Alcon Inc, Sells Zillow ...
GuruFocus.com
Jan-25-22 11:00AM  
2 Beaten-Down Cathie Wood Growth Stocks to Buy and Hold For 10 Years
Motley Fool -7.34%
Jan-24-22 05:38PM  
Orgel Wealth Management, LLC Buys Vanguard S&P Small-Cap 600 ETF, iShares Core S&P 500 ...
GuruFocus.com
Jan-18-22 05:01PM  
Exact Sciences Presents Data Showing Improved Accuracy of Second-generation Cologuard® Test and Progress Toward an Even Better Colorectal Cancer Screening Solution for Patients
PR Newswire
01:38PM  
CHICAGO TRUST Co NA Buys Mastercard Inc, The Home Depot Inc, Boston Scientific Corp, Sells ...
GuruFocus.com
Jan-12-22 10:45AM  
Why Exact Sciences Stock Plunged in 2021
Motley Fool
Jan-09-22 07:00PM  
Exact Sciences Announces Preliminary Fourth Quarter 2021 Results
PR Newswire
07:00PM  
Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy Response for More Patients
PR Newswire
07:00PM  
Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients
PR Newswire
Jan-07-22 06:15PM  
Exact Sciences (EXAS) Gains As Market Dips: What You Should Know
Zacks
Jan-06-22 05:38PM  
Canton Hathaway, LLC Buys Amplify Lithium & Battery Technology ETF, Raytheon Technologies ...
GuruFocus.com
Jan-03-22 06:00AM  
Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR Newswire
Dec-23-21 10:04AM  
Exact Sciences (EXAS) Rides on Cologuard Sales Amid COVID Fear
Zacks
Dec-19-21 06:38AM  
Voya VARIABLE PRODUCTS TRUST Buys Avalara Inc, Bio-Techne Corp, Roku Inc, Sells Spotify ...
GuruFocus.com
Dec-18-21 09:38PM  
Wanger Advisors Trust Buys Bill.com Holdings Inc, Avalara Inc, Etsy Inc, Sells Teradyne Inc, ...
GuruFocus.com
Dec-17-21 09:04AM  
10 Best Genomics Stocks to Buy Now
Insider Monkey
Dec-13-21 11:30AM  
Is Cathie Wood's Genomic ETF a Buy After Sinking This Year?
Motley Fool
Dec-09-21 09:12AM  
Exact Sciences' (EXAS) Oncotype DX Test Study Data Favorable
Zacks -6.01%
Dec-08-21 09:09PM  
EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock?
Insider Monkey
05:38PM  
Moors & Cabot, Inc. Buys NVIDIA Corp, Nike Inc, Procter & Gamble Co, Sells Splunk Inc, ...
GuruFocus.com
11:30AM  
New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making
PR Newswire
Dec-07-21 02:33PM  
Cathie Woods ARK Portfolio: Top 15 Losers
Insider Monkey
07:56AM  
2 Reasons to Buy Exact Sciences Stock, and 1 Reason to Sell
Motley Fool
Dec-03-21 09:46AM  
Heres Why Exact Sciences (EXAS) Landed in RiverParks Detractor List
Insider Monkey
Dec-02-21 11:31AM  
Why Is Exact Sciences (EXAS) Down 14.9% Since Last Earnings Report?
Zacks
05:38AM  
Zacks Market Edge Highlights: Lululemon, Exact Sciences, Pinterest, PayPal and Shopify
Zacks
03:00AM  
Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test
PR Newswire
Dec-01-21 05:05PM  
Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test
PR Newswire -5.96%
03:23PM  
Growth Stock Sell-Off: What Should You Do?
Zacks
05:35AM  
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
Motley Fool
Nov-30-21 03:18PM  
Bioscience nonprofit spurs $658M economic impact on Arizona, report says
American City Business Journals
Nov-29-21 06:44AM  
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
Motley Fool
Nov-25-21 09:43AM  
Cathie Woods ARK Funds Bought Robinhood and Exact Sciences, Sold Tesla.
Barrons.com
Nov-24-21 11:18AM  
Telehealth startup Nurse Disrupted raises $700,000 led by Exact Sciences CEO
American City Business Journals
06:50AM  
These 2 Cathie Wood Stocks Are Screaming Buys
Motley Fool
Nov-23-21 11:03AM  
Heres Why Artisan Partners Reduced its Exact Sciences Corp. (EXAS) Position
Insider Monkey
09:08AM  
New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as Predictor of Prostate Cancer Outcomes in Clinically Low-Risk Patients
PR Newswire
Nov-22-21 11:13AM  
Cathie Woods Genomics Fund Is Down 27% and Outflows Are Growing
Bloomberg
Nov-18-21 08:30AM  
Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection
PR Newswire
Nov-16-21 06:38AM  
3 Beaten-Down Genomics Stocks: Can They Recover?
Motley Fool
Nov-04-21 08:14AM  
Section 32 Raises $740 Million Venture Fund
PR Newswire
Nov-03-21 09:37AM  
Exact Sciences (EXAS) Q3 Earnings and Revenues Beat Estimates
Zacks
06:24AM  
Exact Sciences Shares Drop After Guiding Lower Screening Revenue For FY21
Benzinga
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zanotti Katherine SDirectorJun 30Sale40.131,08643,58160,318Jul 01 06:20 PM
Doyle James EdwardDirectorJun 07Option Exercise16.523,00049,56042,830Jun 08 04:02 PM
Doyle James EdwardDirectorMar 17Option Exercise16.5210,000165,20039,830Mar 18 04:24 PM
Conroy Kevin TPresident and CEOMar 17Option Exercise6.38236,6221,509,5691,167,606Mar 18 04:22 PM
Elliott Jeffrey ThomasChief Financial OfficerMar 01Sale76.694,050310,59419,128Mar 02 05:22 PM
COWARD D SCOTTChief Legal OfficerMar 01Sale76.693,912300,01116,234Mar 02 05:25 PM
Conroy Kevin TPresident and CEOMar 01Sale76.6914,2991,096,590930,984Mar 02 05:28 PM
Condella SarahEVP, Human ResourcesMar 01Sale76.692,816215,95985,762Mar 02 05:31 PM
Condella SarahEVP, Human ResourcesFeb 28Option Exercise0.005,881088,578Mar 02 05:31 PM
Conroy Kevin TPresident and CEOFeb 28Option Exercise0.0029,8870945,283Mar 02 05:28 PM
COWARD D SCOTTChief Legal OfficerFeb 28Option Exercise0.008,288020,146Mar 02 05:25 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 28Option Exercise0.008,462023,178Mar 02 05:22 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 24Sale70.104,717330,66215,037Feb 25 06:31 PM
COWARD D SCOTTChief Administrative OfficerFeb 24Sale70.105,815407,63111,858Feb 25 06:37 PM
Condella SarahSVP, Human ResourcesFeb 24Sale70.104,717330,66288,177Feb 25 06:43 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 24Sale70.105,897413,38014,716Feb 25 06:33 PM
Conroy Kevin TPresident and CEOFeb 24Sale70.1027,1261,901,533915,396Feb 25 06:40 PM
Conroy Kevin TPresident and CEOFeb 23Option Exercise0.0058,6430942,522Feb 25 06:40 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Option Exercise0.0012,747020,613Feb 25 06:33 PM
Condella SarahSVP, Human ResourcesFeb 23Option Exercise0.0010,197092,894Feb 25 06:43 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Option Exercise0.0012,747017,673Feb 25 06:37 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Option Exercise0.0010,197019,754Feb 25 06:31 PM
COWARD D SCOTTChief Administrative OfficerFeb 23Sale69.051,10976,5764,926Feb 24 07:07 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 23Sale69.051,12577,6819,557Feb 24 07:10 PM
Conroy Kevin TPresident and CEOFeb 23Sale69.055,188358,231883,879Feb 24 07:14 PM
Condella SarahSVP, Human ResourcesFeb 23Sale69.051,12477,61282,697Feb 24 07:16 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 23Sale69.051,557107,5117,866Feb 24 07:20 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 22Option Exercise0.003,11209,423Feb 24 07:20 PM
Condella SarahSVP, Human ResourcesFeb 22Option Exercise0.002,247083,821Feb 24 07:16 PM
Conroy Kevin TPresident and CEOFeb 22Option Exercise0.0010,3730889,067Feb 24 07:14 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Option Exercise0.002,247010,682Feb 24 07:10 PM
COWARD D SCOTTChief Administrative OfficerFeb 22Option Exercise0.002,24706,035Feb 24 07:07 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 22Sale72.721,749127,1878,435Feb 23 05:13 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 18Option Exercise74.133,649270,50010,184Feb 23 05:13 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 15Sale79.551,839146,2926,311Feb 16 08:14 PM
Condella SarahSVP, Human ResourcesFeb 15Sale79.5593874,61881,574Feb 16 08:17 PM
COWARD D SCOTTChief Administrative OfficerFeb 15Sale79.551,813144,2243,788Feb 16 07:58 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 15Sale79.5594074,7776,535Feb 16 08:01 PM
Conroy Kevin TPresident and CEOFeb 15Sale79.5514,4091,146,236878,694Feb 16 08:08 PM
Conroy Kevin TPresident and CEOFeb 14Option Exercise19.53222,3164,342,004893,103Feb 16 08:08 PM
ORVILLE JACOB AGeneral Manager, New VenturesFeb 14Option Exercise78.332,030159,0107,475Feb 16 08:01 PM
COWARD D SCOTTChief Administrative OfficerFeb 14Option Exercise78.333,972311,1275,601Feb 16 07:58 PM
Condella SarahSVP, Human ResourcesFeb 14Option Exercise78.332,030159,01082,512Feb 16 08:17 PM
Elliott Jeffrey ThomasChief Financial OfficerFeb 14Option Exercise78.333,972311,1278,150Feb 16 08:14 PM
Conroy Kevin TPresident and CEONov 01Sale93.8816,9221,588,637664,380Nov 03 05:01 PM
Conroy Kevin TPresident and CEOOct 01Sale93.6417,0781,599,184681,302Oct 05 05:26 PM
Conroy Kevin TPresident and CEOSep 01Sale104.4218,9781,981,683698,380Sep 03 04:05 PM
Conroy Kevin TPresident and CEOAug 02Sale107.5019,9702,146,775717,358Aug 04 04:36 PM
Zanotti Katherine SDirectorJul 30Sale111.111,381153,43934,741Aug 02 04:44 PM
Doyle James EdwardDirectorJul 30Sale111.172,640293,48929,830Aug 02 04:42 PM
Elliott Jeffrey ThomasChief Financial OfficerJul 29Sale111.4038,3614,273,530206Aug 02 04:46 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.